Nature's BioCeuticals Denmark ApS: Financial statements 2025
CVR: 41912367
Source: annual report 2025, Danish Business Authority
01/07/2024 – 30/06/2025
Nature's BioCeuticals Denmark ApS (CVR 41912367) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -129,477 and a net result of DKK -611,024 compared with DKK -897,649 the year before. Equity in the 2025 report amounted to DKK 12,151,659. The solvency ratio was 92.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -129,477
- Profit/Loss
- DKK -611,024
- Equity
- DKK 12,151,659
- Total Assets
- DKK 13,112,701
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -129K | -611K | 12.2M | 1 |
| 2024 | - | -400K | -898K | -2M | - |
| 2023 | - | -849K | -1.4M | -1.2M | - |
| 2022 | - | -944K | -1.5M | -1.5M | - |
Official annual report
How creditworthy is Nature's BioCeuticals Denmark ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout Nature's BioCeuticals Denmark ApS
Nature's BioCeuticals Denmark ApS is a Danish company of the type Anpartsselskab based in Odense M, founded in 2020. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The company was previously named Egehoj Development ApS. The management consists of Francois Jean Martin Susini. The company is owned by Green Vault Group. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -129,477 and a net result of DKK -611,024 compared with DKK -897,649 the year before. Equity in the 2025 report amounted to DKK 12,151,659.